Sanofi (SNYNF) Return on Invested Capital (2016 - 2020)

Sanofi has disclosed Return on Invested Capital across 5 years of filings, most recently posting 0.0% for Q2 2020.

• Return on Invested Capital for Q2 2020 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Jun 2020 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital came in at 0.0% for Q2 2020 at Sanofi, up from 0.0% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 5.44% in Q3 2016 to a low of 0.0% in Q1 2018.
• The 5-year median for Return on Invested Capital is 0.0% (2017), against an average of 0.39%.
• Peak annual rise in Return on Invested Capital reached 0 bps in 2017, while the deepest fall reached 544 bps in 2017.
• Sanofi's Return on Invested Capital stood at 0.0% in 2016, then dropped by 21 bps to 0.0% in 2017, then tumbled by 34 bps to 0.0% in 2018, then jumped by 81 bps to 0.0% in 2019, then soared by 54 bps to 0.0% in 2020.
• The last three Return on Invested Capital figures came in at 0.0% (Q2 2020), 0.0% (Q1 2020), and 0.0% (Q4 2019), per Business Quant data.